Basit öğe kaydını göster

dc.contributor.authorDOĞAN, MUSTAFA
dc.contributor.authorERDEM, İLKNUR
dc.contributor.authorKaraali, Ritvan
dc.contributor.authorTOPÇU, BİROL
dc.date.accessioned2021-03-02T17:30:38Z
dc.date.available2021-03-02T17:30:38Z
dc.date.issued2020
dc.identifier.citationDOĞAN M., TOPÇU B., Karaali R., ERDEM İ., "Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection", VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.26, ss.43-48, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_8a258091-0af0-4cd8-94cb-2eaf0327f079
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3896
dc.identifier.urihttps://doi.org/10.4274/vhd.galenos.2020.2020.0016
dc.description.abstractObjectives: This study aimed to investigate the effect of treatment with direct-acting antivirals (DAAs) on the virological response and on the some parameters used to evaluate liver function in cases with chronic liver disease due to hepatitis C virus (HCV) genotype 1b.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleEvaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection
dc.typeMakale
dc.relation.journalVIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
dc.contributor.departmentTekirdağ Namık Kemal Üniversitesi , ,
dc.identifier.volume26
dc.identifier.issue2
dc.identifier.startpage43
dc.identifier.endpage48
dc.contributor.firstauthorID2285329


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster